FibroGen Reports First Quarter 2024 Financial Results

SAN FRANCISCO, May 06, 2024 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the first quarter 2024 and provided an update on the company’s recent developments.

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks